Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    23032159 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Study in Children to Evaluate Non-Inferiority and Persistence up to 5 Years of GSK Bio Meningococcal Vaccine 134612
Condition: Infections, Meningococcal
Interventions: Biological: meningococcal vaccine 134612;   Biological: Mencevax™ ACWY;   Biological: Meningitec™

Indicates status has not been verified in more than two years